Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 328

2.
3.

Functional role of lipoprotein receptors in Alzheimer's disease.

Jaeger S, Pietrzik CU.

Curr Alzheimer Res. 2008 Feb;5(1):15-25. Review.

PMID:
18288927
4.

Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism.

Poirier J.

Ann N Y Acad Sci. 2000;924:81-90. Review.

PMID:
11193807
5.

ApoE: crossroads between Alzheimer's disease and atherosclerosis.

Stojakovic T, Scharnagl H, März W.

Semin Vasc Med. 2004 Aug;4(3):279-85. Review.

PMID:
15630629
6.

Pharmacogenetic basis for therapeutic optimization in Alzheimer's disease.

Cacabelos R.

Mol Diagn Ther. 2007;11(6):385-405. Review.

PMID:
18078356
7.

Quantification of APP and APLP2 mRNA in APOE genotyped Alzheimer's disease brains.

Johnston JA, Norgren S, Ravid R, Wasco W, Winblad B, Lannfelt L, Cowburn RF.

Brain Res Mol Brain Res. 1996 Dec 31;43(1-2):85-95.

PMID:
9037522
8.

Expression of APP pathway mRNAs and proteins in Alzheimer's disease.

Matsui T, Ingelsson M, Fukumoto H, Ramasamy K, Kowa H, Frosch MP, Irizarry MC, Hyman BT.

Brain Res. 2007 Aug 3;1161:116-23.

PMID:
17586478
9.

[Alzheimer's disease. Present and future role of genetics].

Roks G.

Tijdschr Gerontol Geriatr. 2003 Feb;34(1):13-20. Dutch.

PMID:
12629906
10.

Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease.

Martins IJ, Berger T, Sharman MJ, Verdile G, Fuller SJ, Martins RN.

J Neurochem. 2009 Dec;111(6):1275-308. Review.

PMID:
20050287
11.

APP, APOE, complement receptor 1, clusterin and PICALM and their involvement in the herpes simplex life cycle.

Carter CJ.

Neurosci Lett. 2010 Oct 11;483(2):96-100. doi: 10.1016/j.neulet.2010.07.066. Review.

PMID:
20674675
12.

LRP1 modulates APP trafficking along early compartments of the secretory pathway.

Waldron E, Heilig C, Schweitzer A, Nadella N, Jaeger S, Martin AM, Weggen S, Brix K, Pietrzik CU.

Neurobiol Dis. 2008 Aug;31(2):188-97. doi: 10.1016/j.nbd.2008.04.006.

PMID:
18559293
13.

Functional interactions of APP with the apoE receptor family.

Hoe HS, Rebeck GW.

J Neurochem. 2008 Sep;106(6):2263-71. doi: 10.1111/j.1471-4159.2008.05517.x. Review.

14.

Association analysis of genes involved in cholesterol metabolism located within the linkage region on chromosome 10 and Alzheimer's disease.

Riemenschneider M, Mahmoodzadeh S, Eisele T, Klopp N, Schwarz S, Wagenpfeil S, Diehl J, Mueller U, Foerstl H, Illig T, Kurz A.

Neurobiol Aging. 2004 Nov-Dec;25(10):1305-8.

PMID:
15465627
15.

Association studies testing for risk for late-onset Alzheimer's disease with common variants in the beta-amyloid precursor protein (APP).

Nowotny P, Simcock X, Bertelsen S, Hinrichs AL, Kauwe JS, Mayo K, Smemo S, Morris JC, Goate A.

Am J Med Genet B Neuropsychiatr Genet. 2007 Jun 5;144B(4):469-74.

PMID:
17427190
16.

Pharmacogenomics in Alzheimer's disease.

Cacabelos R.

Mini Rev Med Chem. 2002 Feb;2(1):59-84. Review.

PMID:
12369958
17.

[Molecular basics of Alzheimer's disease].

Grigorenko AP, Rogaev EI.

Mol Biol (Mosk). 2007 Mar-Apr;41(2):331-45. Review. Russian.

PMID:
17514900
18.
19.

LRP and Alzheimer's disease.

Zerbinatti CV, Bu G.

Rev Neurosci. 2005;16(2):123-35. Review.

PMID:
15959937
20.

Genetic study of Sardinian patients with Alzheimer's disease.

Piscopo P, Manfredi A, Malvezzi-Campeggi L, Crestini A, Spadoni O, Cherchi R, Deiana E, Piras MR, Confaloni A.

Neurosci Lett. 2006 May 1;398(1-2):124-8.

PMID:
16423463
Items per page

Supplemental Content

Support Center